Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

1,316

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

May 31, 2006

Conditions
Influenza
Interventions
BIOLOGICAL

Fluzone® (Aventis Pasteur inactivated influenza vaccine)

A/H1N1, A/New Caledonia/20/99; A/H3N2, A/Fujian/411/2002; B, B/Shanghai/361/2002

Trial Locations (2)

20050

Pentagon, Washington D.C.

20307

Walter Reed Army Medical Center, Washington D.C.

All Listed Sponsors
collaborator

Walter Reed Army Medical Center

FED

collaborator

United States Army Medical Materiel Development Activity

FED

collaborator

Centers for Disease Control and Prevention

FED

collaborator

Uniformed Services University of the Health Sciences

FED

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

U.S. Air Force Office of the Surgeon General

FED

lead

U.S. Army Medical Research and Development Command

FED

NCT00283283 - Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine | Biotech Hunter | Biotech Hunter